Evaline Tsai

Private Equity Investor at

Gigascale Capital

Finance

Consumer Services

Health Technology

Profile

Evaline Tsai was the founder of Cambridge Cancer Genomics Ltd., founded in 2016, and served as Chief Technology Officer from 2016 to 2018.
Dr. Tsai is currently a Partner at Gigascale Capital Advisors LLC, starting in 2023.
Former positions include Principal at Costanoa Venture Capital Management LLC in 2020 and Senior Associate at Fine Structure Ventures from 2021 to 2022.
Education includes a doctorate from the University of Cambridge conferred in 2019 and an undergraduate degree from Princeton University conferred in 2015.

Evaline Tsai active positions

Companies	Position	Start
Gigascale Capital Gigascale Capital Investment ManagersFinance Gigascale Capital invests in companies located in the United States. The firm targets companies operating of clean energy, advanced manufacturing, grid infrastructure and physical AI sectors. It participates in pre-seed, seed and early stage capital requirements.	Private Equity Investor	01/01/2023

All active positions of Evaline Tsai

Former positions of Evaline Tsai

Companies	Position	End
Fine Structure Ventures Fine Structure Ventures Investment ManagersFinance Fine Structure Ventures invests in companies located across the globe. The firm targets companies operating in the fields of disruptive scientific and technological innovation sectors. It provides financing for pre-seed, seed, early and later stage capital requirements.	Private Equity Analyst	01/12/2022
Costanoa Venture Capital Management LLC Costanoa Venture Capital Management LLC Investment ManagersFinance Costanoa Ventures invests in companies located in the United States primarily in Latin America, Europe, Africa and Australia. The firm targets companies operating in the fields of fintech, data & developer infrastructure, applied AI and cyber & national security. It participates in seed and early stage transactions and also acts as lead investor.	Private Equity Investor	30/11/2020
Cambridge Cancer Genomics Ltd. Cambridge Cancer Genomics Ltd. Pharmaceuticals: MajorHealth Technology Provides cancer research and therapy services	Founder	31/12/2018

See the detail of Evaline Tsai's experience

Training of Evaline Tsai

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Evaline Tsai's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Princeton University Princeton University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Costanoa Venture Capital Management LLC Costanoa Venture Capital Management LLC Investment ManagersFinance Costanoa Ventures invests in companies located in the United States primarily in Latin America, Europe, Africa and Australia. The firm targets companies operating in the fields of fintech, data & developer infrastructure, applied AI and cyber & national security. It participates in seed and early stage transactions and also acts as lead investor.	Finance
Cambridge Cancer Genomics Ltd. Cambridge Cancer Genomics Ltd. Pharmaceuticals: MajorHealth Technology Provides cancer research and therapy services	Health Technology
Fine Structure Ventures Fine Structure Ventures Investment ManagersFinance Fine Structure Ventures invests in companies located across the globe. The firm targets companies operating in the fields of disruptive scientific and technological innovation sectors. It provides financing for pre-seed, seed, early and later stage capital requirements.	Finance
Gigascale Capital Gigascale Capital Investment ManagersFinance Gigascale Capital invests in companies located in the United States. The firm targets companies operating of clean energy, advanced manufacturing, grid infrastructure and physical AI sectors. It participates in pre-seed, seed and early stage capital requirements.	Finance